COMMUNIQUÉS West-GlobeNewswire

Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
27/07/2026
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil, Switzerland – July 27, 2026 Idorsia Ltd (SIX: IDIA) has [...]
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
27/07/2026
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growth FB102 Phase 1b studies in vitiligo and celiac [...]
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
27/07/2026
ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the [...]
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
26/07/2026
ALISO VIEJO, Calif., July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286 shares of RxSight’s [...]
SugarReset Official Lunch2026 Natural Blood Sugar Support Drops for Healthy Glucose Levels Available in USA, Sugar Reset Highlights Ingredient, Supplement Facts
26/07/2026
Discover everything you need to know about SugarReset Blood Sugar Drops in this comprehensive guide. Learn how this natural blood sugar supplement supports healthy blood sugar levels. Read our detailed Sugar Reset [...]
BloodPril Launch 2026 Natural Blood Pressure Support Capsule Highlights Ingredients, Supplement Facts Available Blood Pril in the USA
26/07/2026
BloodPril is a effective blood pressure support supplement formulated with carefully selected natural ingredients and essential nutrients to help maintain healthy blood pressure levels already within the normal range, [...]
CogniHoney Opens Up Its 2026 Formula: What the Four-Ingredient Label Shows About Baobab Fiber and Spermidine
26/07/2026
Cogni Honey Publishes Updated Ingredient, Serving, Label, and Safety Information for Its Current Dietary Supplement Formula Largo, FL, July 25, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
ARCPOINT PROVIDES LEADERSHIP UPDATE
25/07/2026
GREENVILLE, South Carolina, July 24, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces today that Peter Kendall has stepped down as Interim Chief Executive Officer of the Company [...]
HorseFil Publishes Full Milligram Amounts for All Seven Ingredients: Tongkat Ali 200 mg, Serving Directions, and Safety Information for 2026
25/07/2026
HorseFil's Tongkat Ali, Maca Root, Ashwagandha, and Horny Goat Weed Amounts Per Gummy Ogden, UT, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. HorseFil [...]
ColestZen Publishes Ingredient Facts for Its 18-Ingredient Supplement Formula: Serving Directions and Safety Information for 2026
24/07/2026
ColestZen's Bitter Melon, Cinnamon, Licorice, and Gymnema Sylvestre Ingredient Forms Tallmadge, OH, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. [...]
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
24/07/2026
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, [...]
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
24/07/2026
DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS) (the “Company” or “Pelthos”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday [...]
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
24/07/2026
ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant [...]
Maxim Hair Restoration Named Top US Hair Restoration Brand 2026, Reinforcing Its Position Among the Best Hair Restoration Clinics in America
24/07/2026
The nationally recognized award highlights Maxim Hair Restoration's physician-led care, advanced technology, and personalized approach that have earned it a reputation as one of the best hair restoration clinics in [...]
LifeMD to Report Second Quarter 2026 Financial Results on August 5
24/07/2026
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, [...]
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
24/07/2026
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “ [...]
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
24/07/2026
ZURICH, SWITZERLAND , July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in the design and development of next-generation cancer therapeutics, held an Extraordinary General [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/07/2026
WALTHAM, Mass., July 24, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/07/2026
NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]

Pages